VIC 2024 Mid-Year Report

Our mid-year update showcases a remarkable first half of 2024, with substantial product development and commercialization progress, new private investments, and key advancements in FDA clearance.

Click Here to download The Mid-Year Report or view it below.

2024_MidYear_ExecutiveSummary

2024_MidYear_ExecutiveSummary2

2024_MidYear_ExecutiveSummary3

2024_MidYear_ExecutiveSummary4

2024_MidYear_ExecutiveSummary5

2024_MidYear_ExecutiveSummary6

2024_MidYear_ExecutiveSummary7

2024_MidYear_ExecutiveSummary8

2024_MidYear_ExecutiveSummary9

2024_MidYear_ExecutiveSummary10

2024_MidYear_ExecutiveSummary11

2024_MidYear_ExecutiveSummary12

2024_MidYear_ExecutiveSummary13

2024_MidYear_ExecutiveSummary14

2024_MidYear_ExecutiveSummary15

To learn more, visit, victech.com

Technology Solutions For A Better World

Our mission is to form and grow life science and emerging technology companies that shape the future by bringing innovative discoveries from research labs to commercial deployment.

Subscribe to the VIC newsletter.

Privacy Policy